The epithelial ovarian cancer drug pipeline analysis examines the development of innovative therapies targeting the most prevalent form of ovarian cancer. With a growing emphasis on immunotherapy, targeted treatments, and ongoing clinical trials, the pipeline is expanding to address unmet medical needs and improve survival outcomes for women affected by this aggressive disease. https://www.expertmarketresearch.com/clinical-trials/epithelial-ovarian-cancer-drug-pipeline-insight